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Abstract 
There is growing interest in the potential health benefits of diets that involve regular periods 
of fasting. While animal studies have provided compelling evidence that feeding patterns 
such as alternate-day fasting can increase longevity and reduce incidence of many chronic 
diseases, the evidence from human studies is much more limited and equivocal. 
Additionally, although several candidate processes have been proposed to contribute to the 
health benefits observed in animals, the precise molecular mechanisms responsible remain 
to be elucidated. The study described here examined the effects of an extended fast on 
gene transcript profiles in peripheral blood mononuclear cells from ten apparently healthy 
subjects, comparing transcript profiles after an overnight fast, sampled on four occasions at 
weekly intervals, with those observed on a single occasion after a further 24 hours of fasting. 
Analysis of the overnight fasted data, revealed marked inter-individual differences, some of 
which were associated with parameters such as gender and subject body mass. For 
example, a striking positive association between body mass index and the expression of 
genes regulated by type 1 interferon was observed. Relatively subtle changes were 
observed following the extended fast. Nonetheless, the pattern of changes was consistent 
with stimulation of fatty acid oxidation, alterations in cell cycling and apoptosis and 
decreased expression of key pro-inflammatory genes. Stimulation of fatty acid oxidation is 
an expected response, most likely in all tissues, to fasting. The other processes highlighted 
provide indications of potential mechanisms that could contribute to the putative beneficial 
effects of intermittent fasting in humans. 
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Introduction 
There is growing interest in the potential health benefits of diets that involve regular periods 
of fasting (Robertson and Mitchell 2013; Trepanowski et al. 2011). It is postulated that this 
pattern of eating better reflects the periods of feast and famine that the human genome has 
evolved to cope with (Halberg et al. 2005). Studies in animals suggest that certain patterns 
of feeding such as alternate-day fasting may offer similar health benefits to long-term caloric 
restriction, in terms of increased longevity and reduced risks of developing chronic diseases 
such as cardiovascular disease (CVD), dementia and certain cancers (Trepanowski et al. 
2011). Additionally, intermittent fasting might be considered more readily achievable by 
human subjects than long-term caloric restriction, although considerable personal 
commitment and self-control is required to sustain this regimen voluntarily over protracted 
periods (Heilbronn et al. 2005b).  
 
A range of possible mechanisms underlying the apparent benefits of intermittent fasting has 
been proposed. These include increased efficiency of metabolic fuel usage, decreased 
systemic inflammation, reduced circulating IGF and increased cell survival via modulation of 
apoptosis and enhanced cytoprotection (Robertson and Mitchell 2013). However, the key 
molecular mechanisms are currently poorly defined.  Moreover, the evidence to support 
health benefits of intermittent fasting in humans is currently rather limited. Studies of 
individuals choosing to undergo periods of fasting for religious reasons have often provided 
conflicting findings, perhaps due to limited experimental control in these types of study, or 
because of inadequately long periods of fasting (Trepanowski et al. 2011). Comparatively 
few studies of intermittent fasting have been performed with human subjects using well 
defined and controlled dietary interventions and, even in these cases, the findings are not 
always consistent (Heilbronn et al. 2005a; Heilbronn et al. 2005b; Johnson et al. 2007; 
Klempel et al. 2012; Kroeger et al. 2012; Soeters et al. 2009). 
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The study described here examined the acute effects of a single extended fast on gene 
transcript profiles in peripheral blood mononuclear cells (PBMC). PBMC have been used as 
an accessible source of cells for a wide range of human studies. A compromise is often 
made in selecting these cells, as they are frequently not the primary target for clinical or 
nutritional interventions. Nonetheless, the comparative ease with which PBMC can be 
obtained from blood samples and the scope for serial sampling continue to make them a 
prime target for future studies and, in particular, for gene/protein expression-based 
biomarker development. Indeed, current evidence suggests that PBMC may prove useful in 
biomarker development, through the application of functional genomic techniques, for an 
increasingly wide range of clinical conditions (Mohr and Liew 2007). Some of these are 
conditions in which PBMC are directly involved in the disease process. In other cases, 
PBMC are not known to be directly involved in the pathology of the condition but 
nonetheless appear to exhibit characteristic responses as the disease develops and 
progresses. Such responses may reflect the role of PBMC in the body as sentinels (Mohr 
and Liew 2007). Alternatively, PBMC also exhibit some ectopic expression of tissue-specific 
genes that may follow a pattern of response indicative of that occurring in less accessible 
tissues (Liew et al. 2006). 
 
With this in mind, it is important to understand the degree of inter- and intra-individual 
variation, and to characterise both the patterns and magnitude of responses observed in 
PBMC compared with those in the less accessible target tissues. This information is required 
not only for assessing the validity of PBMC for biomarker development but also for 
developing designs of future studies employing functional genomic techniques to ensure 
appropriate statistical power. We and others have previously described variations in gene 
transcript profiles of PBMC from apparently healthy human subjects (Eady et al. 2005; 
Radich et al. 2004; Whitney et al. 2003). Such studies consistently demonstrate substantial 
inter-individual variation. On the other hand, there is typically much less day-to-day variation 
between samples from the same individual. In the study described here, the analysis has 
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been extended to compare baseline inter- and intra-individual transcriptome variation with 
the scale of response to a simple nutritional challenge; in this case an extended (36 h) fast. 
This work was undertaken as part of the NuGO Proof of Principle Study in which 
metabolomic and proteomic techniques were also applied to components of blood, urine and 
saliva to obtain a comprehensive overview of normal phenotypic variation between and 
within individuals and the response to extended fasting (Baccini et al. 2008; Bouwman et al. 
2011; Rubio-Aliaga et al. 2011). 
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Materials and Methods 
The design of the study has been described in detail previously (Baccini et al. 2008). The 
study was performed in accordance with the principle of the Declaration of Helsinki. Ethical 
permission for the study was obtained from the North of Scotland Research Ethics Services 
prior to the start of the study, and all volunteers gave informed consent. Ten healthy 
volunteers (3 males and 7 females, body mass index (BMI) range 18.5 to 39.7 kg/m2 and 
age range 25 to 56 years) were enrolled at the Rowett Institute of Nutrition and Health, 
University of Aberdeen. The volunteers were asked to come to the Human Nutrition Unit 
once a week on different days each week during a four week period after an overnight fast to 
provide a blood, saliva and 24 h urine samples. After the fourth sampling day, volunteers 
were fasted for an additional 24 h (total of 36 h) followed by a final sample collection. Blood 
was collected into vacutainers containing potassium EDTA anticoagulant. PBMC were 
isolated using the OptiprepTM method as described previously (de Roos et al. 2008). A 
portion of the PBMC from each sample was transferred immediately to lysis buffer (Qiagen 
RNEasy Midi kit) and the cells ruptured by passing the lysate through a 21G needle. The 
lysates were snap frozen and stored at -80°C. RNA was prepared from the lysates using 
RNEasy Midi kits according the manufacturer’s instructions and stored at -80 °C. RNA purity 
and yield were assessed using a Nanodrop 1000 spectrophotometer. Aliquots of the purified 
RNA samples were used to prepare biotin labelled cDNA using GeneChip Expression 3’ 
Amplification OneCycle  Target labelling kits (Affymetrix) and hybridized to Affymetrix human 
GeneChip® arrays custom made for NuGO (www.nugo.org) by ServiceXS (Leiden, 
Netherlands) using the manufacturer’s standard protocols. 
 
Array data analysis 
Quality control of the array data was performed using a dedicated software pipeline (De 
Groot et al. 2008). The data were normalized using the GC-RMA method with “full model” 
option. Only genes with a normalised signal ≥ 20 on at least 2 arrays were considered to be 
expressed and included in the subsequent statistical analysis. The array data and sample 
7 
 
information have been made available in MIAME-compliant format in the ArrayExpress 
database (accession number E-MTAB-2922). 
 
Data for expressed genes for all 50 samples were analysed on a log2-scale within the R 
software suite using a linear model including effects for subject, BMI, fasting and the 
interactions of fasting with gender and BMI as well as the three-way interaction of fasting, 
gender and BMI. The main effects of gender and BMI were analysed separately using the 
expressed genes dataset for the 40 overnight fasted (baseline) samples arrays only. 
Probability values were adjusted for multiple testing using the Benjamini Hochberg method 
for false discovery rate control. Apparent functional relationships between genes identified 
through these analyses were investigated further using DAVID Bioinformatic Resources 6.7 
(Huang da et al. 2009a; Huang da et al. 2009b), GO-Elite (Zambon et al. 2012) to test for 
enrichment of pathways included in Wikipathways (www.wikipathways.org) using Cytoscape 
(www.cytoscape.org) for visualization, and BiblioSphere literature mining software 
(Genomatix Software GmbH, Munich, Germany). 
 
Real time RT-qPCR 
The expression profiles of a number of genes, selected on the basis of array data analysis, 
were checked by real time RT-qPCR.  The RT-qPCR was performed using an ABI Prism 
7300 (Applied Biosystems) for each of 4 test genes (CDKN1A, IER3, CLU and IFI44L) plus 
the reference gene RNA polymerase II. Expression of the test genes was determined using 
pre-designed TaqMan® Gene Expression Assay kits specific for each gene (Life 
technologies products Hs00355782_m1, Hs004187506_g1, Hs00156548_1m and 
Hs00915292_m1). The probe and primers used for determination of RNA polymerase II 
mRNA levels were as described previously (Hurst et al. 2008). A one-step RT-PCR reaction 
was employed for all genes. Real time RT-qPCR reactions were carried out in a 96 well plate 
using Taqman® 1-step RT-PCR mastermix reagent kits (Life Technologies) in a total volume 
of 25 µl/well consisting of 250 nM probe, 900 nM forward and reverse primers. Test samples 
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(30 ng of total RNA per reaction) were analysed by comparison with a standard curve, 
included on each plate, consisting of serial dilutions (120, 60, 30,15 and 7.5 ng/well) of a 
pooled PBMC RNA reference sample (r2 for log linear fit of standard curves was >0.99 in all 
cases). The real time RT-qPCR conditions were as follows: 48°C for 30 min, then 95°C for 
10 min, followed by 40 amplification cycles of 95°C for 15 s and 60°C for 1 min. Reactions 
were carried out in triplicate and data were analysed by the ABI PRISM 7300 detection 
system software. Within plate intra-assay variation, based on the average coefficient of 
variations for the triplicate analyses of all test samples, ranged from 5 to 9% for all genes 
analysed.  The data generated for each of the test genes, using the relative standard curve 
method, were normalized against the mean value obtained in the same way for RNA 
polymerase II (Radonic et al. 2004). Pearson correlation analysis was used to compare the 
array and real time RT-qPCR data for these genes and linear regression to analyse the 
relationship between IFI44L mRNA levels and BMI. Paired t-tests were used to compare 
mRNA levels for each of the genes, based on the real time RT-qPCR data, in overnight 
fasting versus extended fast samples. 
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Results and Discussion 
The quality control analysis (De Groot et al. 2008) suggested that high quality consistent 
data were obtained from all arrays with one possible exception. Standard quality metrics for 
Affymetrix GeneChip arrays (scaling factors, ratio of signal for 3’ and 5’ GAPDH and β-actin 
probes, percentage of genes called “present” and background levels) were all within 
standard acceptable ranges, except for the one possible outlier (the array for the extended 
fast sample from volunteer 7) for which the ratio of signal for 3’ and 5’ GAPDH and β-actin 
probes were high and both the array-array intensity correlation and Ward cluster analyses 
performed after data normalization highlighted this array as a marginal outlier. Based on this, 
subsequent statistical analyses were performed initially both with and without the data from 
this array. Comparison of the outputs suggested that exclusion of this array had little effect 
on the overall findings. Therefore, the full dataset was employed.  
 
Of the 23941 probesets represented on the array, 10449 or 10397 passed the criteria for 
representing expressed genes (i.e. normalized signals of ≥20 on at least 2 of the arrays) in 
the full set of 50 arrays or the subset of 40 baseline arrays, respectively. 
 
Baseline data: association of expression profiles with gender, subject and BMI 
The linear model analysis of the 40 baseline array subset incorporating data from the 10397 
probesets for expressed genes suggested significant differences (FDR<5%) between the 
genders in the expression of genes represented by 3013 probesets (29% of expressed 
genes) and between subjects in the expression of genes represented by 2468 probesets 
(24% of expressed genes) (online resource 1). As might be expected, many of the genes 
that exhibited the most marked differences between the genders were found to be located 
on the X or Y chromosomes (e.g. 16 of the 20 genes with the lowest p values) and there was 
notable overlap with genes identified previously as exhibiting highly gender-specific 
expression (e.g. X- and Y-linked ribosomal proteins S4, Jumonji, AT rich interactive domain 
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1D, Y-linked DEAD box polypeptide 3, chromosome Y open reading frame 15B, X-linked 
eukaryotic translation initiation factor 1A and x-linked zinc finger protein) (Eady et al. 2005). 
 
The linear model analysis of the 40 baseline arrays also suggested that BMI was 
significantly associated with the expression of genes represented by 343 probesets 
(FDR<5%; 3% of expressed genes) (online resource 1). This contrasts with only 3 genes 
(CD151 antigen, transforming growth factor beta-induced 68kDa protein and interferon-
induced protein 44-like [IFI44L]) for which significant associations with BMI were observed in 
our previous study (Eady et al. 2005). Of the 3 BMI-associated genes identified previously, 
only IFI44L was represented in the list of genes corresponding to the 343 probesets from the 
current study. Based on this observation, we selected IFI44L as one of the genes for further 
analysis by real time RT-qPCR. The real time RT-qPCR data obtained closely matched the 
array data for this gene (r=0.905, p<0.0001 for the Pearson correlation analysis) and 
reconfirmed the observation of a positive association between IFI44L mRNA levels and BMI 
(r2=0.405, p<0.0001) (Fig. 1). 
 
Fig. 1 Association of IFI44L mRNA levels 
in peripheral blood mononuclear cells with 
BMI of the donors. Real time RT-qPCR 
analysis of IFI44L mRNA levels in PBMC 
samples normalized against expression of 
the reference gene RNA polymerase II. 
Error bars indicate mean ± SEM for 
overnight fasted samples (n=4) from each 
donor. Linear regression analysis results: r2 
= 0.405, 95% confidence interval for slope 
0.03225 to 0.07605, p<0.0001). 
 
 
 
 
Relatively little is known about the function of IFI44L. However, it is one of a group of 7 
genes that have been put forward as potential biomarkers specific for type 1 IFN bioactivity 
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(Malhotra et al. 2011). All of these genes have IFN-stimulated response element sequences 
in their promoters close to the sites of initiation of transcription and their expression is 
increased in vivo in PBMC following INFβ treatment in multiples sclerosis patients. 
Transcript levels for all these genes also have been shown to exhibit dose dependent 
increases in primary PBMC treated in vitro with INFβ but not with INFγ (Malhotra et al. 2011).  
Interestingly, of these 7 genes, 4 were present in the list of genes exhibiting significant 
association with BMI in the current study (IFI44L, myxovirus resistance 1 [MX1], radical S-
adenosyl methionine domain containing 2 [RSAD2] and HECT domain and RCC1-like 
domain-containing protein 5 [HERC5]) all exhibiting a positive association between BMI and 
expression levels (p<10-5). A fifth (interferon-induced protein with tetratricopeptide repeats 1 
[IFIT1]) fell just outside the criteria set for statistical significance (adjusted p value = 0.076). 
The remaining 2 genes (interferon, alpha-inducible protein 27 [IFI27] and ubiquitin specific 
peptidase 18 [USP18]) from the set of 7 had not been included in the statistical analysis as 
they failed to meet the criteria set for expressed genes. A number of other genes shown 
previously to be up-regulated by type 1 IFN in endothelial cells were also present in the list 
of genes significantly associated with BMI (Indraccolo et al. 2007). These were OASL, 
OAS1, OAS2, OAS3, RTP4/IFRG28, HERC6, ISG15, SP110 and PSMB9 and the 
expression of each of these also exhibited an apparent positive association with BMI. 
 
Transcript levels of IFN regulated genes have been highlighted as exhibiting significant inter-
individual variation in PBMC in a number of studies (Eady et al. 2005; Radich et al. 2004; 
Whitney et al. 2003). To our knowledge no direct association between increased type 1 IFN 
activity and obesity in humans has been reported to date. However, in mice, transcription of 
the IFNβ gene in white adipose tissue has been shown to be positively associated with body 
mass (Weisberg et al. 2003), and interferon regulatory factor 7, a master regulator of type 1 
IFN response, is up-regulated in white adipose tissue, liver and gastrocnemius muscle in 
response to high fat diet-induced or genetic obesity (Wang et al. 2013b). IFNα treated mice 
exhibit changes in fatty acid metabolism that appear to arise from impacts both on fatty acid 
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synthesis in the liver and lipolysis in fat cells (Feingold et al. 1992; Feingold et al. 1989; 
Margalit et al. 2006) and other members of the IFN regulatory factor family appear to 
regulate metabolic processes and may play functional roles in some of the pathological 
conditions associated with obesity (Wang et al. 2013a). 
 
In humans, obese individuals undergoing type 1 IFN therapy for chronic viral hepatitis often 
exhibit reduced or no response to the treatment and this is associated with lower induction of 
genes such as MX1, MX2, RSAD2, USP18, IFI6, IFI27, OAS1 and OAS2 in PBMC following 
the therapy (Aggarwal et al. 2008). This appears to align with observations that PBMCs from 
individuals with elevated baseline expression of type 1 IFN-regulated genes exhibit reduced 
responsiveness to IFNα treatment ex vivo, as measured by induction of MX1 mRNA levels 
(Radich et al. 2004) and PBMC isolated from obese individuals exhibit an impaired type 1 
IFN response to toll-like receptor ligands (Teran-Cabanillas et al. 2013), suggesting that 
obesity may lead to abnormal type 1 IFN signalling. 
 
Effects of extended fast on PBMC transcription profiles 
In contrast to the marked gender, subject and BMI associated differences in PBMC gene 
transcript profiles, the effects of the extended fast (36h), as examined using the full set of 
arrays, were much more difficult to detect. In fact, using the same criteria (FDR<5%) with a 
linear model also taking into account, gender, BMI and subject effects, no genes would be 
considered to be significantly affected by the extended fast. However, using less 
conservative statistical criteria (unadjusted p<0.05 and >1.4 fold change in expression), as 
employed previously in similar human studies (Bouwens et al. 2007), genes represented by 
48 probesets would be considered to be significantly affected by the extended fast (Table 1). 
Of these, 15 had been identified as being differentially expressed in the only previous study 
of gene expression in PBMCs in vivo following varying periods of fasting in human subjects 
(Bouwens et al. 2007). Expression of 13 of these 15 changed in the same direction as 
reported previously, including increases also confirmed previously by real time RT-qPCR in 
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certain PPARα regulated genes such a pyruvate dehydrogenase kinase isoform 4 (PDK4), 
carnitine palmitoyltransferase 1 (CPT1) and carnitine/acylcarnitine translocase (SLC25A20) 
(Bouwens et al. 2007).  Increases in PDK4 and CPT1 are also observed in response to 
fasting in skeletal muscle where these changes correspond to metabolic shifts to 
accommodate the fasting state: the increase in PDK4 inhibiting pyruvate dehydrogenase 
thereby acting to conserve glucose, and the increase in CPT1 indicating the up-regulation of 
fatty acid import into mitochondria for β-oxidation (Pilegaard et al. 2003). 
 
Entrez gene identifiers were obtained for 44 of the 48 probesets identified as apparently 
being regulated following the extended fast. Of these, 42 mapped to unique identifiers. Gene 
annotation enrichment analysis, performed with this list of 42 genes using the DAVID 
Bioinformatic Resources 6.7 (Huang da et al. 2009a; Huang da et al. 2009b), identified 
statistically significant enrichment for a small number of functional annotation categories 
most of which related to cytokine/chemokine activity (Table 2). In a similar manner, we also 
used the GO-Elite package to perform over-representation analysis of pathways in 
WikiPathways (applying the following cut-off: z-score ≥ 1.96, permuted p-value ≤ 0.05 and a 
minimum of 3 changed genes). A network visualization the pathways identified and the 
genes involved in them also emphasized the regulation of certain cytokines and 
inflammatory responses, or pathways with an important inflammatory component, in 
response to the extended fast. Additionally, this analysis highlighted over-representation of 
genes involved in adipogenesis and senescence and autophagy pathways (online resource 
2). 
 
Potential functional associations between these genes were investigated further using the 
Bibliosphere literature mining tool. Of the 42 unique Entrez genes identifiers, 38 genes 
passed the initial co-citation filter (i.e. 38 of the genes were co-cited in PubMed at the 
abstract level with at least one other gene in the list either directly or via a common 
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transcription factor). The software was used to generate a network of the 24 genes that were 
directly co-cited at the abstract level (Fig. 2). This highlighted two main clusters of genes 
centred on (a) the cyclin-dependent protease inhibitor CDKN1A and (b) tumour necrosis 
factor alpha (TNF). 
 
 
 
Fig. 2 Shortest path co-citation network of genes for which transcript levels were significantly 
altered following extend fast generated using BiblioSphere software. Open and shaded 
boxes indicate significant up and down-regulation of transcript levels, respectively. Lines 
indicate genes co-cited within PubMed at the abstract level. Open arrowheads indicate 
evidence of regulation. Closed arrowheads indicate evidence of activation. Blocked 
arrowheads indicate evidence of inhibition. Grey arrowheads indicate enzymatic 
modification. Open circles indicate connection annotated by Molecular Connections experts. 
Shaded circles indicate connection annotated by Genomatix experts. 
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In line with the known function of TNF, many of the genes in the cluster around it are 
associated with inflammation. In fact, the simultaneous down-regulation of TNF, interleukin 
1β (IL1B), the chemokine CXCL2, the immediate early genes IER3 and NFKBIZ is 
suggestive of a moderate anti-inflammatory response to the extended fast. Both TNF and 
IL1B are known to stimulate the expression of CXCL2, NFKBIZ and IER3 at the level of the 
gene transcripts in a variety of cells (Shen et al. 2005; Sparna et al. 2010). As reported 
previously, multiplex immunoassay analysis of plasma samples from the same subjects 
showed a small but significant reduction in circulating IL1B protein concentrations that 
parallels the change in PMBC IL1B mRNA levels observed here (Bouwman et al. 2011). The 
data from the multiplex immunoassay also identified moderate but significant reductions in 
certain other inflammatory cytokines and chemokines such as interleukins 8 and 16 and 
monocyte chemotactic protein-1 (MCP-1/CCL2) (Bouwman et al. 2011). TNF levels also 
appeared to decrease, but this did not achieve statistical significance. However, virtually all 
of the analytes detected with this multiplex platform as being significantly increased in 
plasma following the extended fast were pro-inflammatory molecules (e.g. EN-RAGE, MIP-
1β) or well established biomarkers of inflammation (e.g. C reactive protein, ferritin, vascular 
cell adhesion molecule-1, TIMP-1 and complement 3), suggesting that the extended fast 
elicited a systemic pro-inflammatory response that may be quite distinct from the effects 
observed in the PBMC. 
 
The second cluster of genes centred on CDKN1A. This is not one of the genes that were 
previously identified as being affected by fasting in PBMC from human volunteers (Bouwens 
et al. 2007). However, CDKN1A mRNA levels have been reported to increase in a range of 
tissues (muscle, liver, brain and kidney) in fasted mice (Ebert et al. 2010; Hakvoort et al. 
2011; Mitchell et al. 2010; Swindell 2008; Zhang et al. 2011). The cluster of genes around 
CDKN1A in the network includes a number of genes that regulate cell cycling/proliferation 
and cellular senescence. This reflects the pivotal role CDKN1A plays in blocking cell cycling 
and regulating apoptosis following cellular stresses and DNA damage (Jung et al. 2010). 
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Many of the genes in this cluster are known to regulate directly the transcription of CDKN1A, 
exhibit co-ordinated expression together with CDKN1A or be regulated at the level of 
transcription through the actions of CDKN1A. For example, ID3, for which the mRNA levels 
were down-regulated following the extended fast, inhibits expression of CDKN1A while the 
transcription factor TAL1, for which the mRNA levels where up-regulated following the 
extended fast, is known to bind to the CDKN1A promoter and induce its expression 
(Lacombe et al. 2010). Expression of DDIT4, for which mRNA levels were up-regulated 
following the extended fast, is increased in parallel with increased  CDKN1A in response to 
oxidative and other cellular stresses (Han et al. 2008) and in liver following treatment with 
glucocorticoids; hormones that help to regulate blood glucose during fasting (Wong et al. 
2010).  
 
Expression of clusterin at the level of mRNA is, at least in part, dependent on CDKN1A 
(Chen et al. 2004). Clusterin, for which the mRNA levels increased following the extended 
fast, is a regulator of apoptosis and its expression is used as a marker of cell senescence 
(Petropoulou et al. 2001; Trougakos et al. 2006). However, care must be taken in 
interpreting clusterin mRNA levels as the nuclear form of the protein is pro-apoptotic 
whereas the secreted form is anti-apoptotic (Petropoulou et al. 2001; Shannan et al. 2006). 
 
There is also complex interplay between TNF and CDKN1A in the regulation of lymphocyte 
proliferation, inflammation and apoptosis. Mitogen activation of human primary lymphocytes 
in vitro results in an increase in both TNF and CDKN1A mRNA levels, whereas treatment 
with the immunosuppressant cyclosporin, which inhibits T lymphocyte proliferation, reduces 
TNF mRNA levels but increases expression of CDKN1A both at the level of mRNA and 
protein (Khanna 2005).  Treatment of human PBMC with TNF in vitro increases apoptosis 
and necrosis via a process that involves increases in levels of CDKN1A protein 
(Ryazantseva et al. 2010). TNF has also been shown to stimulate CDKN1A expression, both 
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at the level of mRNA and protein in murine alveolar cells and macrophages, while CDKN1A 
can suppress TGF-β induced TNF expression (Yamasaki et al. 2008).  
 
Real time RT-qPCR analysis 
To assess the validity of the findings from the array data, mRNA levels for three of the genes 
identified from the array analysis as being affected by the extended fast (CDKN1A, clusterin 
and IER3) were also analysed by real time RT-qPCR.  In all three cases, the real time RT-
qPCR data corresponded closely to the values obtained from the arrays (r > 0.9, p<0.001 for 
Pearson correlation analysis of the real time RT-qPCR and array data for each gene) and 
there were significant changes (p<0.05) in the mRNA levels measured by real time RT-
qPCR for all three genes, that matched the changes detected with the array data (Fig. 3). 
 
 
Fig. 3 Effects of an extended fast on the levels of (a) CDKN1A, (b) clusterin and (c) IER3 
mRNAs. Each line indicates the relative mRNA levels for a different individual after overnight 
(baseline) and extended (36 hour) fasts. Real time RT-qPCR data for each gene were 
normalised first against levels of the reference gene RNA polymerase II and then against the 
mean normalized value for the baseline values. 
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Conclusions 
This study provides new insights into effects of prolonged fasting on gene transcript profiles 
in PBMC in vivo. In particular, in addition to confirming changes in the expression of genes 
involved in fatty acid oxidation and glucose metabolism that have been described previously 
(Bouwens et al. 2007), we also observed changes in a number of key genes involved in 
inflammatory, cell cycle and apoptotic processes. These align well with some of the 
mechanisms proposed, but not yet conclusively demonstrated, to play a role in the increased 
longevity and reduced incidence of chronic disease associated with caloric restriction and 
intermittent fasting in animal models and with changes in biomarkers of these conditions in 
humans (Robertson and Mitchell 2013; Trepanowski et al. 2011). In human subjects, longer 
term intermittent fasting, undertaken for Ramadan or as part of a weight loss study, has 
been reported to attenuate circulating levels of certain pro-inflammatory cytokines such as 
IL1B, TNF and IL6 and inflammatory markers such as CRP (Aksungar et al. 2007; Faris et 
al. 2012; Kroeger et al. 2012). The transcriptomic analysis performed here, together with the 
targeted proteomic analysis described previously, suggest that moderate reductions in 
inflammatory cytokines can be detected following just one extended fast. However, plasma 
concentrations of certain other inflammatory markers, such as C reactive protein, were noted 
to be elevated following the extended fast. This suggests a more complex mechanism than 
simply a broad spectrum attenuation of inflammatory signals.  
 
The magnitudes of the changes in gene transcript levels brought about by the extended fast 
were generally rather small, particularly when considered in relation to the substantial inter-
individual difference observed. Using relatively low stringency statistical criteria, only 48 
genes were found to be significantly affected by the extended fast. This contrasts with one 
previous study of the effect of fasting on gene transcription profiles in PBMC from human 
subjects, which identified 1200 and 1386 genes that changed, according to the same criteria, 
after 24 and 48 hours of fasting, respectively (Bouwens et al. 2007). This apparent 
discrepancy is likely to be due largely to two key differences in the study designs. Firstly, 
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Bouwens and co-workers compared transcript profiles after 24 or 48 hours of fasting with 
those obtained immediately after a meal (i.e. the fed state) whereas the comparison made 
here was between overnight fasted and 36 hour fasted samples. Secondly, the group of 
subjects in the previous study was much more homogeneous (males subjects aged 19-22 
years with BMI >19 and <25 kg/m2) than that in the current study (both male and female 
subjects aged 25 to 56 years with BMI ranging from 18.5 to 39.7 kg/m2).  
 
One of the key aims of the current study was to evaluate the scale of response to a simple 
nutritional intervention, detected using transcriptomic, proteomic and metabolomic methods, 
in relation to the normal biological background variation. With this in mind, we decided to 
examine what might be considered the worst case scenario, in which a minimal number of 
inclusion / exclusion criteria were applied, thus creating the potential for a highly 
heterogeneous study group. Nonetheless, one of the conclusions from this work is that all 
three functional genomic approaches are capable of detecting responses to a simple 
nutritional challenge, even on a background of substantial inter-individual variation. 
Moreover, the array and real time RT-qPCR data described here highlight that, in addition to 
the inter-individual differences at baseline, there also appear to be significant inter-individual 
differences in the response to the nutritional challenge.  Use of more homogeneous study 
populations may well help to reduce such variability and could, therefore, be considered 
beneficial when employing functional genomic methods for detecting the often subtle effects 
of nutritional interventions although such studies would need to be followed up to determine 
whether or not equivalent effects are observed in other groups of subjects.  
 
The counter side to this argument is that use of heterogeneous study populations can itself 
provide opportunities for new findings. For example, we observed a striking positive 
association between subject BMI and the expression of type 1 IFN regulated genes that we 
would have been unlikely to see in a group with less variation in BMI. This is the second 
study in which we have observed a positive association between BMI and mRNA levels for 
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IFI44L, a gene considered as a potential marker of type 1 IFN bioactivity (Malhotra et al. 
2011), in human PBMCs (Eady et al. 2005). Direct measurement of INFα activity is very 
difficult, which is why the transcript levels of genes regulated by IFNα are currently widely 
used as markers of bioactivity (Malhotra et al. 2011). The evidence obtained in this study 
strongly suggests a relationship between BMI and type 1IFN activity that merits further 
investigation. However, any future studies would need to take into account the observation 
that the transcript levels of many IFN regulated genes vary not only between individuals, but 
also between multiple samples from the same individual. Thus, repeated sampling from 
subjects, as performed here, may be required to overcome problems with intra-individual 
variability and enable the association to be tested rigorously. 
 
In summary, PBMC gene transcriptome analysis of the baseline samples, collected after an 
overnight fast on four separate occasions, again highlighted the marked degree of inter-
individual variation and provided new insights into potential associations between 
parameters such as BMI and gene transcript profiles. In particular, a positive association 
between BMI and the expression of genes regulated by type 1 IFN was observed. The scale 
of response to the extended fast (36h) at the level of the transcriptome within PBMC 
appeared to be rather subtle and difficult to detect against the background of substantial 
inter-individual variation. Nonetheless, the pattern of changes described here is consistent 
with stimulation of fatty acid oxidation, alterations in a number of genes involved in cell 
cycling and apoptosis, and a decrease in the expression of a number of key pro-
inflammatory genes. This last observation contrasts with evidence of a systemic pro-
inflammatory response to the extended fast reported previously (Bouwman et al. 2011), and 
may provide the first evidence for a more fundamental anti-inflammatory response to fasting 
that could contribute to the putative beneficial effects of intermittent fasting in humans. 
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